Unknown

Dataset Information

Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells.


ABSTRACT: Glioblastoma stem-like cells (GSC) are hypothesized to evade current therapies and cause tumor recurrence, contributing to poor patient survival. Existing cell surface markers for GSC are developed from embryonic or neural stem cell systems; however, currently available GSC markers are suboptimal in sensitivity and specificity. We hypothesized that the GSC cell surface proteome could be mined with a yeast display antibody library to reveal novel immunophenotypes. We isolated an extensive collection of antibodies that were differentially selective for GSC. A single domain antibody VH-9.7 showed selectivity for five distinct patient-derived GSC lines and visualized orthotopic GBM xenografts in vivo after conjugation with a near-infrared dye. These findings demonstrate a previously unexplored

SUBMITTER: Zorniak M 

PROVIDER: S-EPMC5696472 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature